Saint Luke's Newsroom

Sep. 18, 2024

FOX4: Saint Luke's Holds Moment of Silence for Physician Suicide Awareness

National Physician Suicide Awareness Day highlights the alarming rates of physician suicide and the need for greater support in the health care industry.
Sep. 16, 2024

JAMA Medical News: Even After CPR, Surviving Out-of-Hospital Cardiac Arrest Might Be Influenced by Race, Sex

A new study provides evidence that even among those who receive CPR, Black or female individuals are less likely to survive an out-of-hospital cardiac arrest than White or male individuals.
Sep. 11, 2024

KSHB: New Ruling Says Patients Must Be Notified of Breast Density After a Mammogram

Dr. Mary Mitchell, chief of breast radiology at Saint Luke's, talks to KSHB about what dense breast tissue is and how it impacts your risk of developing breast cancer.
Sep. 6, 2024

TIME: Is Tennis Really the 'World's Healthiest Sport'? We Fact-Checked the Claim

TIME talked to Dr. James O'Keefe about research that found tennis can positively impact a person's longevity.
Sep. 6, 2024

BBC News: Studies Reveal New Effects of Semaglutide

BBC News talked to Dr. Mikhail Kosiborod about new findings on the cardiovascular effects of semaglutide.
Sep. 6, 2024

BBC Radio: Research Shows New Effects of Semaglutide

Recently published studies have found new effects of semaglutide, including reduced risk of heart conditions and the potential for a reduced risk of cardiovascular death.
Sep. 6, 2024

Times Radio: Research Finds New Positive Impacts of Semaglutide

More than 10 studies presented at the European Society of Cardiology Congress revealed new findings on the far-reaching benefits of semaglutide.
Sep. 4, 2024

Healio: Semaglutide Cuts Risk for Worsening Heart Failure, CV Death Among Adults with HFpEF

Semaglutide cut the risk for worsening heart failure and cardiovascular death for adults with heart failure with preserved ejection fraction, according to new data presented by Dr. Mikhail Kosiborod.
Aug. 31, 2024

American Journal of Managed Care: Semaglutide Enhances Heart Failure Outcomes in Obesity

A new subanalysis presented by Dr. Mikhail Kosiborod shows benefits of semaglutide in patients with aFib.